In this study, we observed that both positive and strongly positive rates of resistin expression are significantly higher in breast cancer tissue specimens compared with normal breast tissue and that both positive and strongly positive resistin expressions are significantly associated with a number of clinicopathological parameters in breast cancer patients. The gene discussed is RETN; the disease is breast carcinoma.